All articles by Phillip Broadwith – Page 15
-
Business
J&J to buy antiviral specialist Alios
$1.75 billion deal brings Phase II compounds for hepatitis C and respiratory syncytial virus
-
Business
Dow’s $1bn price-fixing fine upheld
Firm loses its appeal against damages for fixing polyurethane prices
-
Business
Mitsubishi to buy Japanese gases specialist
Taiyo Nippon Sanso acquisition continues consolidation in Japan’s chemical industry
-
Business
Lumara splits and sells to AMAG and Perrigo
Lumara has just emerged from bankruptcy and brings a drug for suppressing pre-term birth, plus other women’s health products
-
Business
India backs off drug pricing controls
Current price caps will stand, but rules on how new caps can be imposed are being tightened
-
Business
Review says cheaper drug is safe for eye disease
Cochrane collaboration says side effects of expensive Lucentis and off-label Avastin are similar
-
Business
Gilead licenses generic hepatitis C drug in India
Company aims to head off competition and grab a slice of royalties
-
Business
Freeing a world of fixers
Company profile: Sugru mouldable silicone rubber lets you mend what’s broken and hack stuff better
-
Business
Novo Nordisk quits inflammation R&D and cuts jobs
Firm will return to primary focus on diabetes and obesity
-
Business
Halliburton settles Deepwater Horizon claims
Company will pay $1.1bn for damage to property and commercial fishing
-
Business
Exelexis slashes workforce by 70%
Poor clinical trial performance pushes company into cost-cutting drive
-
Business
DuPont settles pollution charges for $1.3m
Allegations relate to eight hazardous chemical leaks in West Virginia between 2006 and 2010
-
Business
Clinical collaborations drive cancer immunotherapy
Companies race to pair up chemotherapy drugs with immune system-boosting antibodies to greatest effect in trials
-
Business
Illumina targets cancer diagnostics
Sequencing will improve tests and speed up clinical trials processes for big pharma partners
-
Business
Sanofi snaps up inhaled insulin licence
Deal gives Mannkind access to global manufacturing and distribution for recently-approved Afrezza
-
Business
Single shot antibiotic approved for skin infections
Third drug in three months approved under US antimicrobials incentive scheme
-
Business
Tetraethyl lead bribery case ends with four executives convicted
Three jailed over corruption to prolong sales of fuel additives in Iraq and Indonesia
-
Business
AstraZeneca stocks respiratory and cancer pipelines
A $2bn deal with Almirall and a raft of acquisitions and partnership deals bulk up two focus areas for the company
-
Business
Bruker winds down underperforming instrument lines
Stand-alone gas chromatographs and certain mass spectrometry products to be sold off
-
Business
Reckitt Benckiser to spin out US pharma arm
Declining heroin addiction treatment sales prompt divestment as company focuses on over-the-counter and consumer products